Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-036156

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Jennifer Balliet
Officer — VP and Chief Culture Officer
Period of report
May 25, 2017
Accepted (ET)
May 30, 2017 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 26, 2017S3,334$7.50D10,049D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted StockF6,F7,F8$0.00May 25, 2017A20,000AMay 25, 2018—Common Stock20,00020,000D
Stock Option (Right to Buy)F1$3.76holding———Apr 16, 2014Apr 16, 2018Common Stock7,5007,500D
Stock Option (Right to Buy)F2$3.45holding———Mar 5, 2015Mar 5, 2019Common Stock15,00015,000D
Stock Option (Right to Buy)F3$4.78holding———May 4, 2016May 4, 2020Common Stock120,000120,000D
Stock Option (Right to Buy)F4$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock50,00050,000D
Stock Option (Right to Buy)F5$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock60,00060,000D

Explanation of responses